Favorable outcome of cancer patients undergoing transcatheter aortic valve replacement

Show full item record



Permalink

http://hdl.handle.net/10138/328168

Citation

Biancari , F , Dahlbacka , S , Juvonen , T , Virtanen , M P O , Maaranen , P , Jaakkola , J , Laakso , T , Niemelä , M , Tauriainen , T , Vento , A , Husso , A , Savontaus , M , Laine , M , Mäkikallio , T , Raivio , P , Eskola , M , Rosato , S , Anttila , V , Airaksinen , J & Valtola , A 2020 , ' Favorable outcome of cancer patients undergoing transcatheter aortic valve replacement ' , International Journal of Cardiology , vol. 315 , pp. 86-89 . https://doi.org/10.1016/j.ijcard.2020.03.038

Title: Favorable outcome of cancer patients undergoing transcatheter aortic valve replacement
Author: Biancari, Fausto; Dahlbacka, Sebastian; Juvonen, Tatu; Virtanen, Marko P.O.; Maaranen, Pasi; Jaakkola, Jussi; Laakso, Teemu; Niemelä, Matti; Tauriainen, Tuomas; Vento, Antti; Husso, Annastiina; Savontaus, Mikko; Laine, Mika; Mäkikallio, Timo; Raivio, Peter; Eskola, Markku; Rosato, Stefano; Anttila, Vesa; Airaksinen, Juhani; Valtola, Antti
Contributor: University of Helsinki, Kardiologian yksikkö
University of Helsinki, Department of Surgery
University of Helsinki, HUS Heart and Lung Center
University of Helsinki, Department of Surgery
University of Helsinki, HUS Heart and Lung Center
Date: 2020-09-15
Language: eng
Number of pages: 4
Belongs to series: International Journal of Cardiology
ISSN: 0167-5273
URI: http://hdl.handle.net/10138/328168
Abstract: Aim The aim of this study was to assess the outcome of transcatheter aortic valve replacement (TAVR) in patients with cancer. Methods This is a retrospective study from the nationwide FinnValve registry on 2130 consecutive patients who underwent TAVR for severe AS from January 2008 to October 2017. Results In this cohort, 417 patients (19.6%) had history of cancer and 113 (5.3%) had an active malignancy at the time of TAVR. Patients with any malignancy had similar late mortality than patients without any malignancy (at 7 years, 65.1% vs. 59.3%, adjusted HR 1.105, 95%CI 0.892–1.369). At 7 years, cancer-related mortality was 22.5% among patients with preoperative cancer, and 11.0% in those without preoperative cancer (p 
Subject: 3122 Cancers
Transcatheter aortic valve replacement
TAVR
TAVI
Cancer
Malignancy
IMPLANTATION
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
1_s2.0_S0167527319355469_main.pdf 797.0Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record